KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Accumulated Depreciation & Amortization (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $570.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 15.62% to $570.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $570.0 million through Dec 2025, up 15.62% year-over-year, with the annual reading at $570.0 million for FY2025, 15.62% up from the prior year.
  • Accumulated Depreciation & Amortization hit $570.0 million in Q4 2025 for Quest Diagnostics, up from $493.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $570.0 million in Q4 2025 to a low of $408.0 million in Q4 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $469.4 million across 5 years, with a median of $439.0 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 0.46% in 2023 and later increased 15.62% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $408.0 million in 2021, then grew by 7.11% to $437.0 million in 2022, then rose by 0.46% to $439.0 million in 2023, then grew by 12.3% to $493.0 million in 2024, then rose by 15.62% to $570.0 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for DGX at $570.0 million in Q4 2025, $493.0 million in Q4 2024, and $439.0 million in Q4 2023.